Table 1.
General clinical information of the patients.
| Variables | MH and ERM | PDR | P-value | P1 | P2 | P3 | |
|---|---|---|---|---|---|---|---|
| (control group) | Non-IVR | IVR | # | § | & | ||
| Patients, n | 11 | 14 | 10 | – | |||
| Age (years) | 65.64 ± 5.14 | 54.71 ± 6.94 | 53.90 ± 7.95 | 0.0003 | 0.001 | 0.001 | 0.95 |
| Female/male | 7/4 | 7/7 | 5/5 | 0.759 | 0.79 | 0.81 | 0.99 |
| DM duration (y) | / | 12.86 ± 4.43 | 16 ± 3.23 | 0.076 | |||
| Hypertension | 4 (36.36%) | 8 (57.14%) | 4 (40%) | 0.543 | 0.57 | 0.98 | 0.70 |
| Visual acuity (LogMar) | |||||||
| Before surgery | 0.82 ± 0.57 | 1.97 ± 0.58 | 1.60 ± 0.86 | <0.001 | <0.001 | 0.001 | 0.577 |
| After surgery | 0.60 ± 0.29 | 1.27+0.39 | 1.49 ± 0.38 | <0.001 | <0.001 | <0.001 | 0.327 |
| Intraocular pressure | |||||||
| Before surgery | 13.27 ± 2.14 | 13.21 ± 3.49 | 14.20 ± 3.67 | 0.72 | 0.99 | 0.77 | 0.74 |
| After surgery | 12.27+1.90 | 17.00 ± 2.71 | 16.40 ± 4.19 | 0.001 | 0.001 | 0.01 | 0.88 |
MH, macular hole; ERM, epiretinal membrane; DM, diabetes mellitus; PDR, proliferative diabetic retinopathy; #Control vs. Non-IVR; §Control vs. IVR; &Non-IVR vs. IVR.
Bold value indicates p < 0.05, which are statistically significant.